Peter Heerma
Corporate Officer/Principal chez TRAVERE THERAPEUTICS, INC.
Fortune : 536 321 $ au 30/04/2024
Profil
Peter Heerma is currently the Chief Commercial Officer at Travere Therapeutics, Inc. Prior to this, he worked as the Director of Commercial Strategy Renal Care at Abbott Laboratories from 2003 to 2012, Senior Director of Portfolio Strategy at AbbVie, Inc. from 2012 to 2015, and General Manager of Oncology & Cardiovascular Products at Amgen, Inc. from 2015 to 2019.
He received his graduate degree from the University of Lund in 1997 and his undergraduate degree from Stenden University in 1996.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 01/02/2024 | 99 503 ( 0,13% ) | 536 321 $ | 30/04/2024 |
Postes actifs de Peter Heerma
| Sociétés | Poste | Début |
|---|---|---|
| TRAVERE THERAPEUTICS, INC. | Corporate Officer/Principal | 01/10/2019 |
Anciens postes connus de Peter Heerma
| Sociétés | Poste | Fin |
|---|---|---|
| AMGEN INC. | Corporate Officer/Principal | 01/09/2019 |
| ABBVIE INC. | Corporate Officer/Principal | 01/11/2015 |
| ABBOTT LABORATORIES | Corporate Officer/Principal | 01/11/2012 |
Formation de Peter Heerma
| University of Lund | Graduate Degree |
| Stenden University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 4 |
|---|---|
| ABBOTT LABORATORIES | Health Technology |
| AMGEN INC. | Health Technology |
| ABBVIE INC. | Health Technology |
| TRAVERE THERAPEUTICS, INC. | Health Technology |
